Načítá se...
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
OBJECTIVE: Increases in hepatic and plasma cholesterol occur in patients with nonalcoholic fatty liver disease (NAFLD), although the reason for this is not well understood. We investigated whether Protease-Activated Receptor 2 (PAR2) plays a role in cholesterol and lipid homeostasis in NAFLD. METHOD...
Uloženo v:
| Vydáno v: | Mol Metab |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6742970/ https://ncbi.nlm.nih.gov/pubmed/31668396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2019.08.019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|